0000898432-22-000660.txt : 20221209 0000898432-22-000660.hdr.sgml : 20221209 20221209104358 ACCESSION NUMBER: 0000898432-22-000660 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221207 FILED AS OF DATE: 20221209 DATE AS OF CHANGE: 20221209 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GLENN JOHN CENTRAL INDEX KEY: 0001253497 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36534 FILM NUMBER: 221453953 MAIL ADDRESS: STREET 1: 7900 HOPYARD ROAD STREET 2: APT 210 CITY: PLEASANTON STATE: CA ZIP: 94577 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IRADIMED CORP CENTRAL INDEX KEY: 0001325618 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 731408526 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1025 WILLA SPRINGS DR. CITY: WINTER SPRINGS STATE: FL ZIP: 32708 BUSINESS PHONE: 4076778022 MAIL ADDRESS: STREET 1: 1025 WILLA SPRINGS DR. CITY: WINTER SPRINGS STATE: FL ZIP: 32708 4 1 form4.xml X0306 4 2022-12-07 0001325618 IRADIMED CORP IRMD 0001253497 GLENN JOHN C/O IRADIMED CORPORATION 1025 WILLA SPRINGS DR. WINTER SPRINGS FL 32708 true Chief Financial Officer Restricted Stock Units 2022-12-07 4 A 0 10504 0 A Common Stock 10504 33687 D Performance-based Restricted Stock Units 2022-12-07 4 A 0 10504 0 A Common Stock 10504 10504 D Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock. The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in full on the third anniversary of the grant date, December 7, 2025. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. The reporting person received performance-based restricted stock units ("PRSUs") under Iradimed Corporation's 2014 Equity Incentive Plan. Vesting of these PRSUs depends on the reporting person's achievement of a specified relative ranking of total stockholder return over a three-year period from December 8, 2022 through December 7, 2025. If the relative measure at December 7, 2025 and for the three-year period then ended is: (i) less than or equal to 80% of the peer group, no vesting would occur, (ii) between 80% and 100% of the peer group, the number of shares vesting would be pro-rata against the nominal granted shares, (iii) equal to 100% of the peer group, the number of shares vesting would be the nominal granted shares, (iv) between 100% and 120% of the peer group, the number of shares vesting would be pro-rata against an additional tranche of the nominal granted shares plus the nominal granted shares, and (v) if 120% or greater of the peer group, the number of shares vesting would be double the nominal granted shares. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of PRSUs that have vested. /s/ John Glenn 2022-12-09